Will Synthetic Biology Firm @Amyris Post Net Income In 2024? Amyris, a #synthetic biology company has been growing revenue through sales of consumer products at #Sephora, and through its ingredients line of business. In an exclusive interview with @MarketBeat, Pinnacle Associates Portfolio Manager @Randy Baron said his models show the company will have a run rate of $1 billion in revenue by Q4 2023. He expects the company to post net income in 2024.
Important Disclosure
Contact Us
Thank you! Your submission has been received. A member of the Pinnacle team will be in touch shortly.
Oops! Something went wrong while submitting the form.